NCT02460991View on ClinicalTrials.gov

A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma

PHASE3TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

June 5, 2017

Study Completion Date

June 5, 2017

Conditions
Hepatocellular CarcinomaHepatomaLiver Cell Carcinoma
Interventions
DEVICE

DEB-TACE

DRUG

Sorafenib

Trial Locations (6)

21201

University of Maryland Medical Center, Baltimore

35233

University of Alabama Hospital, Birmingham

40202

University of Louisville, Louisville

77030

MD Anderson Cancer Center, Houston

90033

University of Southern California, Los Angeles

97239

Oregon Health & Science University, Portland

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY